arrow
C

Christina J. Falcon

Memorial Sloan Kettering Cancer Center
H指数:19
被引数:1,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation

EGFR突变肺癌的临床基因组学分析识别出Rb通路失活是鳞状转化的标志

2026-06-170
PRE
Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC A Multicenter Retrospective Study

继续使用下一代ALK TKIs联合化疗治疗晚期ALK阳性NSCLC的疗效与安全性:一项多中心回顾性研究

2025-12-010
PRE
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer

MTAP缺失的临床意义及其与非小细胞肺癌中包括EGFR在内的并发致癌驱动基因改变的重叠情况

2025-11-170
PRE
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
2024-03-261
OAAI
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
2023-03-1310
OA
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers (vol 13, 1450, 2022)
2022-04-051
OAAI
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
2022-03-1861
OAAI
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers
2021-07-0120
OAAI
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
2021-05-0454
OA
COVID-19 in patients with lung cancer

肺癌患者的新型冠状病毒肺炎

2020-10-01175
OAAI